N-Palmitoylethanolamine depot injection increased its tissue levels and those of other acylethanolamide lipids
Open Access
- 1 August 2013
- journal article
- research article
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. 7, 747-752
Abstract
N-Palmitoylethanolamine (NAE 16:0) is an endogenous lipid signaling molecule that has limited water solubility, and its action is short-lived due to its rapid metabolism. This poses a problem for use in vivo as oral administration requires a high concentration for significant levels to reach target tissues, and injection of the compound in a dimethyl sulfoxide- or ethanol-based vehicle is usually not desirable during long-term treatment. A depot injection of NAE 16:0 was successfully emulsified in sterile corn oil (10 mg/kg) and administered in young DBA/2 mice in order to elevate baseline levels of NAE 16:0 in target tissues. NAE 16:0 levels were increased in various tissues, particularly in the retina, 24 and 48 hours following injections. Increases ranged between 22% and 215% (above basal levels) in blood serum, heart, brain, and retina and induced an entourage effect by increasing levels of other 18 carbon N-Acylethanolamines (NAEs), which ranged between 31% and 117% above baseline. These results indicate that NAE 16:0 can be used as a depot preparation, avoiding the use of inadequate vehicles, and can provide the basis for designing tissue-specific dosing regimens for therapies involving NAEs and related compounds.Keywords
This publication has 45 references indexed in Scilit:
- The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive actionBMC Cancer, 2012
- The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese miceLipids in Health and Disease, 2011
- Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed miceNutrition & Metabolism, 2011
- Lipid Profiling Reveals Tissue‐Specific Differences for Ethanolamide Lipids in Mice Lacking Fatty Acid Amide HydrolaseLipids, 2010
- Intracellular mechanisms of N-acylethanolamine-mediated neuroprotection in a rat model of strokeNeuroscience, 2010
- Biomarkers of Endocannabinoid System Activation in Severe ObesityPLOS ONE, 2010
- Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stressPsychoneuroendocrinology, 2009
- The neuroprotective properties of palmitoylethanolamine against oxidative stress in a neuronal cell lineMolecular Neurodegeneration, 2009
- ‘Entourage’ effects of N‐palmitoylethanolamide and N‐oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptorsBritish Journal of Pharmacology, 2008
- Adjuvant treatment of atopic eczema: assessment of an emollient containing N‐palmitoylethanolamine (ATOPA study)Journal of the European Academy of Dermatology and Venereology, 2007